Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Contact form








 


Note! If you want an answer on a question you must specify your email address




Bo Wängberg

Professor, adjungerad

Bo Wängberg
Professor, adjungerad
bo.wangberg@surgery.gu.se

Postal Address: Sahlgrenska universitetssjukhuset, 41345 Göteborg
Visiting Address: Blå stråket 5, vån 3 su/sahlgrenska , 41345 Göteborg


Department of Surgery at Institute of Clinical Sciences (More Information)
Sahlgrenska Universitetssjukhuset
413 45 Göteborg
Visiting Address: Blå stråket 5, vån 3 SU/Sahlgrenska , 413 45 Göteborg

Latest publications

Optimization of treatment of neuroendocrine tumors with radiolabeled somatostatin analogues
Eva Forssell-Aronsson, Johan Spetz, Viktor Sandblom, Britta Langen, Khalil Helou et al.
Global Academics Programs Conference, Stockholm, May 15-17, 2018., Conference contribution 2018
Conference contribution

Nationellt vårdprogram för adrenala incidentalom
Andreas Muth, Lilian Hammarstedt, Mikael Hellström, Ulf Nyman, Anders Sundin et al.
Läkartidningen, Journal article 2017
Journal article

Showing 41 - 50 of 162

2013

Increased therapeutic effect of fractionated 177Lu-octreotate administration on nude mice bearing human carcinoid tumor GOT1.
Johanna Dalmo, Johan Spetz, H Johansson, Esmaeil Mehrara, Ola Nilsson et al.
SweRays Workshop, Uppsala, Aug 21-23, 2013, Conference contribution 2013
Conference contribution

Increased therapeutic response from fractionated 177 Lu-octreotate therapy of GOT1 tumors in nude mice.
Johan Spetz, Johanna Dalmo, Britta Langen, Toshima Z Parris, Bo Wängberg et al.
Cancerfondens planeringsgrupp för onkologisk radionuklidterapi. Höstmöte, Göteborg, Sverige, Nov 13-15., Other 2013
Other

Fractionated 177Lu-octreotate therapy of GOT1 tumors in nude mice increases treatment efficacy, possibly via SSTR up-regulation
Johan Spetz, Johanna Dalmo, Britta Langen, Toshima Z Parris, Bo Wängberg et al.
59th Annual Meeting of the Radiation Research Society, New Orleans, USA, September 15-19, 2013, Conference contribution 2013
Conference contribution

A multicentre phase II trial evaluating safety and efficacy of activity escalation with 177 Lu-DOTA_TATE in patients with disseminated neuroendocrine tumors, based on detailed dosimetry and patients selection.
A Sundlöv, Johanna Svensson, K Sjögreen Gleisner, Peter Bernhardt, C Hindrof et al.
NANETS annual meeting, Charleston , USA, Okt, 4-6., Conference contribution 2013
Conference contribution

Acquired hypermethylation of the P16INK4A promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutation.
Nimrod Botond Kiss, Andreas Muth, Adam Andreasson, Christofer Carl Juhlin, János Geli et al.
Endocrine-related cancer, Journal article 2013
Journal article

2012

Showing 41 - 50 of 162

Page Manager: Katarina Olinder Eriksson|Last update: 3/7/2013
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?